Dose Proportionality of Licarbazepine Pharmacokinetics after Single and Repeated Oral Doses in Healthy Volunteers

2007 ◽  
Vol 21 (5) ◽  
Author(s):  
Claire Souppart ◽  
Michael Merz ◽  
Sebastien Balez ◽  
Anni Agarwal ◽  
Francois Mercier ◽  
...  
Author(s):  
B.S. Chakraborty ◽  
E.M. Hawes ◽  
G. McKay ◽  
J.W. Hubbard ◽  
E.D. Korchinski ◽  
...  

1992 ◽  
Vol 13 (9) ◽  
pp. 663-669 ◽  
Author(s):  
Michael A. Eldon ◽  
Debbie S. Blake ◽  
Michael J. Coon ◽  
Gerald D. Nordblom ◽  
Allen J. Sedman ◽  
...  

1986 ◽  
Vol 26 (8) ◽  
pp. 628-632 ◽  
Author(s):  
Yih-Chain Huang ◽  
John L. Colaizzi ◽  
Robert H. Bierman ◽  
Robert Woestenborghs ◽  
Joseph J. P. Heykants

1992 ◽  
Vol 4 (3) ◽  
pp. 276-282 ◽  
Author(s):  
Jean-Marie Houle ◽  
Pierre Major ◽  
John McCans ◽  
Hélène Landriault ◽  
Marc LeFebvre ◽  
...  

1981 ◽  
Vol 9 (1) ◽  
pp. 12-17 ◽  
Author(s):  
A Vittoria ◽  
F Laghi Pasini ◽  
G L Messa ◽  
T Di Perri ◽  
G Corvi ◽  
...  

A complete crossover trial was undertaken in six healthy volunteers to gain information on dose-effect responses to indobufen by assessing the intensity and duration of the effect of 3 single oral doses of the drug on platelet aggregation induced by threshold concentration of ADP and by 3 added doses of collagen. The results of the study confirm that the activity is dose-related and is reversible since 24 hours after administration it has practically disappeared. The effect of the same dose of indobufen differed significantly according to the amount of collagen added to plasma, whereas increasing doses of indobufen provoked a significantly more marked effect when the amount of inducer employed was the same.


1992 ◽  
Vol 15 ◽  
pp. 430B ◽  
Author(s):  
K. H. Antonin ◽  
K. Kucher ◽  
L. Fuchs ◽  
P. R. Bieck ◽  
E. Schmidt

1995 ◽  
Vol 39 (5) ◽  
pp. 1082-1086 ◽  
Author(s):  
M. Richer ◽  
S. Allard ◽  
L. Manseau ◽  
F. Vallee ◽  
R. Pak ◽  
...  

Sign in / Sign up

Export Citation Format

Share Document